Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed FCF Margin for 3 consecutive years, with 39713.15% as the latest value for Q1 2018.

  • Quarterly FCF Margin changed N/A to 39713.15% in Q1 2018 from the year-ago period, while the trailing twelve-month figure was 126376.43% through Dec 2018, down 12543767.0% year-over-year, with the annual reading at 7300.68% for FY2025, 46415.0% down from the prior year.
  • FCF Margin for Q1 2018 was 39713.15% at ENDRA Life Sciences, down from 20081.52% in the prior quarter.
  • The five-year high for FCF Margin was 304.81% in Q2 2016, with the low at 39713.15% in Q1 2018.
  • Average FCF Margin over 3 years is 10293.96%, with a median of 1083.98% recorded in 2017.
  • Peak annual rise in FCF Margin hit -228232bps in 2017, while the deepest fall reached -1997559bps in 2017.
  • Over 3 years, FCF Margin stood at 105.93% in 2016, then tumbled by -18857bps to 20081.52% in 2017, then crashed by -98bps to 39713.15% in 2018.
  • According to Business Quant data, FCF Margin over the past three periods came in at 39713.15%, 20081.52%, and 190.46% for Q1 2018, Q4 2017, and Q3 2017 respectively.